Opal Oncology is a single asset company based on a programme that was licensed in from Hershey Cancer Research, USA to develop a novel treatment against Glioblastoma.

Discovering Brain Cancer Therapies
Status Active
Website http://www.opalonc.com/
Category Biotech
Modality Small Molecule
Therapautics Area
Headquaters Cambridge, UK
Partner Business Angels
Investment Portfolio Pre-Fund Investment
Co-Investors Hershey Cancer Research